Anteilseigner
BlackRock Fund Advisors (6,40 %) The Vanguard Group, Inc. (4,86 %) Stonepine Capital Management LLC (4,23 %) MPM BioImpact, Inc (2,74 %) NEA Management Co. LLC (2,31 %) Geode Capital Management LLC (2,06 %) Rosalind Advisors, Inc. (2,01 %) SSgA Funds Management, Inc. (1,94 %) Millennium Management LLC (1,10 %) Renaissance Technologies LLC (0,98 %) Morgan Stanley & Co. LLC (0,84 %) Northern Trust Investments, Inc.(Investment Management) (0,83 %) D. E. Shaw & Co. LP (0,75 %) Redmile Group LLC (0,75 %) Apo Asset Management GmbH (0,68 %) Steven Prestrelski,
PhD, MBA (0,51 %) Medical Strategy GmbH (0,42 %)
Kontakt
Xeris Biopharma Holdings Inc.